JWH-015
JWH-015 is a chemical from the naphthoylindole family, which acts as a cannabinoid receptor type 2 (CB2) agonist. It was developed by the team led by John W. Huffman at Clemson University.
Chemistry[edit | edit source]
JWH-015 is part of the naphthoylindole family of compounds, which are known for their activity on the cannabinoid receptors. It is a CB2 agonist, meaning it binds to this receptor and produces a biological response.
Pharmacology[edit | edit source]
JWH-015 acts as a CB2 agonist. The CB2 receptor is primarily found in the immune system, and its activation results in anti-inflammatory and potentially anti-cancer effects. However, the exact mechanisms of action of JWH-015 are still under investigation.
Research[edit | edit source]
Research on JWH-015 has primarily focused on its potential therapeutic uses. Studies have suggested that it may have anti-inflammatory and anti-cancer properties, although more research is needed to confirm these findings.
See also[edit | edit source]
References[edit | edit source]
JWH-015 Resources | ||
---|---|---|
|
|
|
Find a healthcare provider anywhere in the world quickly and easily!
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD